C-Type Lectin Receptor Mediated Modulation of T2 Immune Responses to Allergens

Abstract

Purpose of Review Allergic diseases represent a major health problem of increasing prevalence worldwide. In allergy, dendritic cells (DCs) contribute to both the pathophysiology and the induction of healthy immune responses to the allergens. Different studies have reported that some common allergens contain glycans in their structure. C-type lectin receptors (CLRs) expressed by DCs recognize carbohydrate structures and are crucial in allergen uptake, presentation, and polarization of T cell responses. This review summarizes the recent literature regarding the role of CLRs in the regulation of type 2 immune responses to allergens. Recent Findings In this review, we highlight the capacity of CLRs to recognize carbohydrates in common allergens triggering different signaling pathways involved in the polarization of CD4+ T cells towards specific Th2 responses. Under certain conditions, specific CLRs could also promote tolerogenic responses to allergens, which might well be exploited to develop novel therapeutic approaches of allergen-specific immunotherapy (AIT), the single treatment with potential disease-modifying capacity for allergic disease. At this regard, polymerized allergens conjugated to non-oxidized mannan (allergoid-mannan conjugated) are next-generation vaccines targeting DCs via CLRs that promote regulatory T cells, thus favoring allergen tolerance both in preclinical models and clinical trials. Summary A better understanding of the role of CLRs in the development of allergy and in the induction of allergen tolerance might well pave the way for the design of novel strategies for allergic diseases.

Pharmacological Material Basis of Chushi Weiling Decoction and Its Mechanism in Eczema and Herpes Zoster Based on UPLC-Q-TOF-MS, GC-MS, and Network Pharmacology

“…The target proteins above have been proven to be key enzymes in metabolic pathways such as the synthesis of estrogen, synthesis of cholesterol, prostaglandin biosynthesis, and arachidonic acid metabolism. [41][42][43][44] This result indicates CWD may have the potential to regulate immune response mechanisms, which are usually the most important in the treatment of eczema and herpes zoster diseases.…”

Non-glycosylated G protein with CpG ODN provides robust protection against respiratory syncytial virus without inducing eosinophilia

“…Soluble glycosylated G proteins inhibit the activation of human dendritic cells by binding to the glycan recognition receptors DC-SIGN and L-SIGN in vitro ( 39 ). The binding of ligands to DC-SIGN has also contributes to the formation of a Th2-biased environment ( 40 – 42 ). In addition, the structural differences between mG and eG, including glycosylation as well as other post-translational modifications and folding, may contribute to immune responses.…”

360° approach to the patient with mite allergy: from scientific evidence to clinical practice

“…New AIT vaccines targeting dendritic cells generated by conjugation of allergoids with non-oxidised mannan have been developed ( 38 – 40 ). In the case of mite allergy treatment, a study has been carried out to find the optimal dose for both, subcutaneous (SCIT) and sublingual (SLIT) administration of polymerised extracts of D. pteronyssinus and D. farinae , conjugated with mannan in a double-blind, placebo-controlled study in patients with perennial allergic rhinitis.…”